Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Targeting IL-10 in Auto-immune Diseases.
Metric Optimization for Surface Analysis in the Laplace-Beltrami Embedding Space.
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Optimization of electron microscopy for human brains with long-term fixation and fixed-frozen sections.
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.
Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells.
Multi-slice myelin water imaging for practical clinical applications at 3.0 T.
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.
Oxidative Modifications of Cerebral Transthyretin are Associated with Multiple Sclerosis.
Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Correction: Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes.
Multiple sclerosis: Sodium channel blocker protects axons in MS models.
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Immunohistochemical study of Krüppel-like factor 4 in the spinal cords of rats with experimental autoimmune encephalomyelitis.
Dual Inhibition of IL-23 and IL-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility.
Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies.
Pages
« first
‹ previous
…
378
379
380
381
382
383
384
385
386
…
next ›
last »